The Patent Finder

Armagen Technologies, Inc.

Also on record
Records under this name other than the patents Armagen Technologies, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.

Back to Armagen Technologies, Inc.

PatentTitleStatus Expires Confidence
US 7,741,446Fusion Antibodies That Cross the Blood-Brain Barrier in Both Directions
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,974,791Methods and Compositions for Increasing Alpha-L-Iduronidase Activity in the CNS
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,567,400Methods and Compositions for Increasing Alpha-L-Iduronidase Activity in the CNS
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,202,467Methods and Compositions for Increasing Alpha-L-Iduronidase Activity in the CNS
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,028,156Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the CNS
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,834,874Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the CNS
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,043,661Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the CNS
Formerly held
In force
 · High confidence
In forceHigh confidence
US 10,011,651Methods and Compositions for Increasing Iduronate 2-Sulfatase Activity in the CNS
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,486,399Methods and Compositions for Increasing Arylsulfatase A Activity in the CNS
Formerly held
In force
 · High confidence
In forceHigh confidence
US 8,920,801Methods and Compositions for Increasing Arylsulfatase a Activity in the CNS
Formerly held
In force
 · High confidence
In forceHigh confidence
10 of 23 patents shown.
Pro members see all 23.
Pro members: see all 23 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited